Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Abbott Laboratories stock opened the day at $123.82 after a previous close of $124.40. The latest price was $125.10 (25 minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD34.6 billion and employs 109,000 staff.
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.
Abiomed stock opened the day at $328.01 after a previous close of $330.53. The latest price was $329.04 (25 minute delay). Abiomed is listed on the NASDAQ, has a trailing 12-month revenue of around USD$812.9 million and employs 1,536 staff.
Align Technology, Inc. , a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.
Align Technology stock opened the day at $608.31 after a previous close of $606.33. The latest price was $594.93 (25 minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$2.5 billion and employs 18,070 staff.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery.
Edwards Lifesciences Corporation stock opened the day at $88.38 after a previous close of $89.08. The latest price was $88.73 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$4.4 billion and employs 14,900 staff.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.
Boston Scientific Corporation stock opened the day at $40.73 after a previous close of $40.91. The latest price was $40.81 (25 minute delay). Boston Scientific Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$9.9 billion and employs 38,000 staff.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.
Medtronic stock opened the day at $125.32 after a previous close of $125.99. The latest price was $125.78 (25 minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$27.9 billion and employs 90,000 staff.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands.
Penumbra stock opened the day at $264.89 after a previous close of $264.90. The latest price was $262.63 (25 minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$560.4 million and employs 3,300 staff.
Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Inogen stock opened the day at $47.94 after a previous close of $47.44. The latest price was $46.89 (25 minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$308.5 million and employs 938 staff.
SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment.
SmileDirectClub stock opened the day at $10.63 after a previous close of $10.52. The latest price was $10.37 (25 minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$607.4 million and employs 4,000 staff.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.